ArticleProceedings of the National Academy of Sciences of the United States of America2017

No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms.

Sofie Mohlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.